Cargando…
The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004–2014)
BACKGROUND: Current prognostic markers cannot adequately predict the clinical outcome of breast cancer patients. Therefore, additional biomarkers need to be included in routine immune panels. FOXA1 was a significant predictor of favorable outcome in primary breast cancer, while Nestin expression is...
Autores principales: | De Lara, Shahin, Nyqvist, Jenny, Werner Rönnerman, Elisabeth, Helou, Khalil, Kenne Sarenmalm, Elisabeth, Einbeigi, Zakaria, Karlsson, Per, Parris, Toshima Z., Kovács, Anikó |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394077/ https://www.ncbi.nlm.nih.gov/pubmed/30819139 http://dx.doi.org/10.1186/s12885-019-5373-2 |
Ejemplares similares
-
Previously diagnosed multiple primary malignancies in patients with breast carcinoma in Western Sweden between 2007 and 2018
por: Nyqvist, Jenny, et al.
Publicado: (2020) -
Metachronous and Synchronous Occurrence of 5 Primary Malignancies in a Female Patient between 1997 and 2013: A Case Report with Germline and Somatic Genetic Analysis
por: Nyqvist, Jenny, et al.
Publicado: (2017) -
Genetic alterations associated with multiple primary malignancies
por: Nyqvist, Jenny, et al.
Publicado: (2021) -
Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry
por: Engqvist, Hanna, et al.
Publicado: (2020) -
Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome
por: Shubbar, Emman, et al.
Publicado: (2013)